Biotech company Scholar Rock lands $47 mln Series C
Scholar Rock, a biotechnology company, has secured $47 million in Series C financing. Invus led the round with participation from other investors that included Redmile Group, Polaris Partners, Timothy Springer, ARCH Venture Partners, EcoR1 Capital, The Kraft Group, Fidelity Management and Research Company and Cormorant Asset Management.
3 January 2018•1 min read
